Relay Therapeutics, Inc.
US ˙ NasdaqGM ˙ US75943R1023

SecurityRLAY / Relay Therapeutics, Inc.
InstitutionBellevue Group AG
Latest Disclosed Ownership7,795,242 shares
Latest Disclosed Value $ 77,562,658
Bellevue Group AG reports 6.59% decrease in ownership of RLAY / Relay Therapeutics, Inc.

On May 14, 2026 - Bellevue Group AG filed a 13F-HR form disclosing ownership of 7,795,242 shares of Relay Therapeutics, Inc. (US:RLAY) valued at $77,562,658 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 8,345,364 shares of Relay Therapeutics, Inc.. This represents a change in shares of -6.59% during the quarter. The current value of the position is $105,391,672 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F RELAY THERAPEUTICS COM 75943R102 7,795,242 -550,122 -6.59 77,563 9.86 1.8332
2026-02-17 2025-12-31 13F RELAY THERAPEUTICS COM 75943R102 8,345,364 -246 -0.00 70,602 62.06 1.3379
2025-11-14 2025-09-30 13F RELAY THERAPEUTICS COM 75943R102 8,345,610 114,740 1.39 43,564 52.97 0.9052
2025-08-14 2025-06-30 13F RELAY THERAPEUTICS COM 75943R102 8,230,870 853,578 11.57 28,479 47.34 0.6277
2025-05-14 2025-03-31 13F RELAY THERAPEUTICS COM 75943R102 7,377,292 0 0.00 19,329 -36.41 0.4331
2025-02-14 2024-12-31 13F RELAY THERAPEUTICS COM 75943R102 7,377,292 108 0.00 30,394 -41.81 0.5851
2024-11-14 2024-09-30 13F RELAY THERAPEUTICS COM 75943R102 7,377,184 1,000,069 15.68 52,230 25.62 0.8462
2024-08-14 2024-06-30 13F RELAY THERAPEUTICS COM 75943R102 6,377,115 450,497 7.60 41,579 -15.47 0.6756
2024-05-15 2024-03-31 13F RELAY THERAPEUTICS COM 75943R102 5,926,618 -9,464 -0.16 49,191 -24.74 0.7502
2024-02-14 2023-12-31 13F RELAY THERAPEUTICS COM 75943R102 5,936,082 1,051,082 21.52 65,356 59.09 0.9997
2023-11-14 2023-09-30 13F RELAY THERAPEUTICS COM 75943R102 4,885,000 714,200 17.12 41,083 -21.58 0.6619
2023-08-14 2023-06-30 13F RELAY THERAPEUTICS COM 75943R102 4,170,800 -1,800 -0.04 52,385 -23.77 0.7472
2023-05-15 2023-03-31 13F RELAY THERAPEUTICS COM 75943R102 4,172,600 -32,220 -0.77 68,723 9.40 0.9973
2023-02-14 2022-12-31 13F RELAY THERAPEUTICS COM 75943R102 4,204,820 0 0.00 62,820 -33.21 0.8338
2022-11-14 2022-09-30 13F RELAY THERAPEUTICS COM 75943R102 4,204,820 172,558 4.28 94,062 39.27 1.3500
2022-08-11 2022-06-30 13F RELAY THERAPEUTICS COM 75943R102 4,032,262 113,300 2.89 67,541 -42.42 0.9548
2022-05-13 2022-03-31 13F RELAY THERAPEUTICS COM 75943R102 3,918,962 -187,000 -4.55 117,295 -6.98 1.3620
2022-02-10 2021-12-31 13F RELAY THERAPEUTICS COM 75943R102 4,105,962 350,000 9.32 126,094 6.47 1.2997
2021-11-12 2021-09-30 13F RELAY THERAPEUTICS COM 75943R102 3,755,962 1,115,000 42.22 118,426 22.55 1.2018
2021-08-12 2021-06-30 13F RELAY THERAPEUTICS COM 75943R102 2,640,962 709,618 36.74 96,633 44.73 0.9433
2021-05-12 2021-03-31 13F RELAY THERAPEUTICS COM 75943R102 1,931,344 521,987 37.04 66,767 13.99 0.7064
2021-02-16 2020-12-31 13F RELAY THERAPEUTICS COM 75943R102 1,409,357 109,357 8.41 58,573 5.79 0.6708
2020-11-16 2020-09-30 13F RELAY THERAPEUTICS COM 75943R102 1,300,000 1,300,000 55,367 0.7650
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.